A single center, non-randomized clinical study to Genolimzumab Injection
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Genolimzumab (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Genor Biopharma
- 11 Dec 2017 Status changed from not yet recruiting to recruiting.
- 02 Sep 2016 New trial record
- 29 Aug 2016 An Investigational Drug Application (IND) has been filed, as reported by a CBT Pharmaceuticals media release.